Acutus Medical Inc Ordinary Shares AFIB
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if AFIB is a good fit for your portfolio.
News
Trading Information
- Previous Close Price
- $0.16
- Day Range
- $0.16–0.17
- 52-Week Range
- $0.16–1.09
- Bid/Ask
- $0.16 / $0.17
- Market Cap
- $5.01 Mil
- Volume/Avg
- 226,525 / 1.0 Mil
Key Statistics
- Price/Earnings (Normalized)
- —
- Price/Sales
- 0.68
- Dividend Yield (Trailing)
- —
- Dividend Yield (Forward)
- —
- Total Yield
- —
Company Profile
Acutus Medical Inc is an arrhythmia management company focused on improving the way cardiac arrhythmias are diagnosed and treated. The company designs, manufactures, and markets a range of tools for catheter-based ablation procedures to treat various arrhythmias. Its product portfolio includes Novel access sheaths, Transseptal crossing tools, Diagnostic and mapping catheters, Ablation catheters, Mapping, and imaging consoles and accessories, as well as Supporting algorithms and Software programs. It markets and sells its electrophysiology products worldwide to hospitals and electrophysiologists that treat patients with arrhythmias. It has a business presence in the United States and Outside the United States.
- Sector
- Healthcare
- Industry
- Medical Devices
- Stock Style Box
- Small Value
- Total Number of Employees
- 233
- Website
- https://www.acutusmedical.com
Valuation
|
Metric
|
AFIB
|
|---|---|
Price/Earnings (Normalized) | — |
Price/Book Value | — |
Price/Sales | 0.68 |
Price/Cash Flow | — |
Price/Earnings
AFIB
Financial Strength
|
Metric
|
AFIB
|
|---|---|
Quick Ratio | 1.78 |
Current Ratio | 2.44 |
Interest Coverage | −1.55 |
Quick Ratio
AFIB
Profitability
|
Metric
|
AFIB
|
|---|---|
Return on Assets (Normalized) | −19.37% |
Return on Equity (Normalized) | −45.04% |
Return on Invested Capital (Normalized) | −20.43% |
Return on Assets
AFIB
Medical Devices Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
ABT
| Abbott Laboratories | Rwqhbgx | Mvwfkk | $185.4 Bil | |
SYK
| Stryker Corp | Cszhbqbfll | Xfjv | $128.2 Bil | |
BSX
| Boston Scientific Corp | Wvwtwxgf | Bbpmhf | $107.7 Bil | |
MDT
| Medtronic PLC | Jcrdhzmkj | Rwtvrw | $105.2 Bil | |
DXCM
| DexCom Inc | Wgmrcfhm | Gycj | $54.7 Bil | |
EW
| Edwards Lifesciences Corp | Brmlrshvz | Yzrnyx | $52.8 Bil | |
ZBH
| Zimmer Biomet Holdings Inc | Qmycnmvwc | Qzr | $24.6 Bil | |
ALGN
| Align Technology Inc | Lpbtptx | Ngksgf | $23.4 Bil | |
PHG
| Koninklijke Philips NV ADR | Scjqbzjy | Wylvtn | $18.7 Bil | |
PODD
| Insulet Corp | Jjzrfgqmy | Nlvsy | $11.5 Bil |